FDA grants Lundbeck Fast Track status for narcolepsy drug candidate

July 23, 2026 3:30 AM

Lundbeck announced that the U.S. Food and Drug Administration has granted Fast Track designation to Lu AH69593, an investigational oral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found